These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis. Pak CY, Adams-Huet B, Sakhaee K, Bell NH, Licata A, Johnston C, Rubin B, Bonnick S, Piziak V, Graham H, Ballard J, Berger R, Fears W, Breslau N, Rubin C. J Bone Miner Res; 1996 Feb; 11(2):160-8. PubMed ID: 8822339 [Abstract] [Full Text] [Related]
3. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures. Gutteridge DH, Stewart GO, Prince RL, Price RI, Retallack RW, Dhaliwal SS, Stuckey BG, Drury P, Jones CE, Faulkner DL, Kent GN, Bhagat CI, Nicholson GC, Jamrozik K. Osteoporos Int; 2002 Feb; 13(2):158-70. PubMed ID: 11908491 [Abstract] [Full Text] [Related]
4. Water fluoridation and osteoporotic fracture. Hillier S, Inskip H, Coggon D, Cooper C. Community Dent Health; 1996 Sep; 13 Suppl 2():63-8. PubMed ID: 8897754 [Abstract] [Full Text] [Related]
5. Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures. Pak CY, Sakhaee K, Zerwekh JE, Parcel C, Peterson R, Johnson K. J Clin Endocrinol Metab; 1989 Jan; 68(1):150-9. PubMed ID: 2909549 [Abstract] [Full Text] [Related]
6. Fluoride therapy of type I osteoporosis. Devogelaer JP, Nagant de Deuxchaisnes C. Clin Rheumatol; 1995 Sep; 14 Suppl 3():26-31. PubMed ID: 8846658 [Abstract] [Full Text] [Related]
7. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy. Meunier PJ, Sebert JL, Reginster JY, Briancon D, Appelboom T, Netter P, Loeb G, Rouillon A, Barry S, Evreux JC, Avouac B, Marchandise X. Osteoporos Int; 1998 Sep; 8(1):4-12. PubMed ID: 9692071 [Abstract] [Full Text] [Related]
8. A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis. Kleerekoper M, Peterson EL, Nelson DA, Phillips E, Schork MA, Tilley BC, Parfitt AM. Osteoporos Int; 1991 Jun; 1(3):155-61. PubMed ID: 1790403 [Abstract] [Full Text] [Related]
9. Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis. Riggs BL, O'Fallon WM, Lane A, Hodgson SF, Wahner HW, Muhs J, Chao E, Melton LJ. J Bone Miner Res; 1994 Feb; 9(2):265-75. PubMed ID: 8140940 [Abstract] [Full Text] [Related]
10. Fluoride treatment of postmenopausal osteoporosis: age, renal function, and other clinical factors in the osteogenic response. Murray TM, Harrison JE, Bayley TA, Josse RG, Sturtridge WC, Chow R, Budden F, Laurier L, Pritzker KP, Kandel R. J Bone Miner Res; 1990 Mar; 5 Suppl 1():S27-35. PubMed ID: 2339633 [Abstract] [Full Text] [Related]
11. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride. Delmas PD, Dupuis J, Duboeuf F, Chapuy MC, Meunier PJ. J Bone Miner Res; 1990 Mar; 5 Suppl 1():S143-7. PubMed ID: 2339624 [Abstract] [Full Text] [Related]
12. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 7. Fluoride therapy for osteoporosis. Murray TM, Ste-Marie LG. CMAJ; 1996 Oct 01; 155(7):949-54. PubMed ID: 8837545 [Abstract] [Full Text] [Related]
13. Effect of intermittent therapy with a slow-release fluoride preparation. Pak CY, Sakhaee K, Zerwekh JE. J Bone Miner Res; 1990 Mar 01; 5 Suppl 1():S149-55. PubMed ID: 2339625 [Abstract] [Full Text] [Related]
14. [Comparative effects of sodium fluoride and hormonal replacement therapy on bone metabolism in osteoporotic women with high fracture risk. Results of monitoring for 2 years]. Pouillès JM, Trémollières F, Ribot C. Rev Rhum Mal Osteoartic; 1992 Feb 01; 59(2):103-13. PubMed ID: 1604221 [Abstract] [Full Text] [Related]
15. Effects of different regimens of sodium fluoride treatment for osteoporosis on the structure, remodeling and mineralization of bone. Balena R, Kleerekoper M, Foldes JA, Shih MS, Rao DS, Schober HC, Parfitt AM. Osteoporos Int; 1998 Feb 01; 8(5):428-35. PubMed ID: 9850350 [Abstract] [Full Text] [Related]
16. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. Riggs BL, Hodgson SF, O'Fallon WM, Chao EY, Wahner HW, Muhs JM, Cedel SL, Melton LJ. N Engl J Med; 1990 Mar 22; 322(12):802-9. PubMed ID: 2407957 [Abstract] [Full Text] [Related]
17. The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride. Hodsman AB, Drost DJ. J Clin Endocrinol Metab; 1989 Nov 22; 69(5):932-8. PubMed ID: 2793995 [Abstract] [Full Text] [Related]
18. Therapy of established postmenopausal osteoporosis with monofluorophosphate plus calcium: dose-related effects on bone density and fracture rate. Ringe JD, Kipshoven C, Cöster A, Umbach R. Osteoporos Int; 1999 Nov 22; 9(2):171-8. PubMed ID: 10367046 [Abstract] [Full Text] [Related]
19. Sustained-release sodium fluoride in the treatment of the elderly with established osteoporosis. Rubin CD, Pak CY, Adams-Huet B, Genant HK, Li J, Rao DS. Arch Intern Med; 2001 Oct 22; 161(19):2325-33. PubMed ID: 11606148 [Abstract] [Full Text] [Related]
20. Anabolic effects of fluoride on bone. Pak CY, Zerwekh JE, Antich P. Trends Endocrinol Metab; 1995 Sep 22; 6(7):229-34. PubMed ID: 11540313 [Abstract] [Full Text] [Related] Page: [Next] [New Search]